BSV is guided by the experience and direction provided by the Board of Directors, comprising of the following eminent personalities:

The Board of Directors formulates the overall business plan and strategy of the Company and monitors the implementation. The core management team consisting of senior production, marketing, finance and research professionals is responsible for the day-to-day operations of the Company and implementation of the Company's plans.

Brief profiles of the Board of Directors:

Dr. Vinod G. Daftary: Dr. Vinod Daftary founded BSV in 1971, primarily for the manufacture and marketing of diagnostic and therapeutic products based on plasma fractions. Given his medical and scientific background, Dr. Daftary realized the need for domestic manufacturing of plasma products. Dr. Vinod Daftary holds a post graduate and doctoral degree in pathology and microbiology from the Walter Reed Hospital, Washington DC.

Dr. Daftary has won several academic and business awards including the Junior Clinical Shirvalkar Gold Medal for Medicine at G.S. Medical College in 1945, the DAHANUKAR ENTREPRENEUR AWARD of Maharashtra Chamber of Commerce for making Anti-D Immuneglobulin for the first time in India, the Certificate Award for Import Substitution for making strips for detection of albumin and glucose in urine and the Import Substitution Award for making Anti-D serum for the first time in India by the then Invention Promotion Grant of the Government of India.

His distinguished and pioneering efforts in the field of plasma products have also led to his having several prestigious scientific memberships like Fellow of the College of American Pathologists, Fellow of the International College of Surgeons, Member of the International Academy of Pathologists, Fellow of the Indian Association of Pathologists & Microbiologists and Fellow of the Indian College of Pathologists.

Mr. Bharat Daftary: Mr. Bharat Daftary is the Managing Director of the Company and is mainly responsible for business strategy, international alliances, sales and marketing. He has been instrumental in striking several fruitful international alliances for BSV and has over the years developed excellent relationships internationally in the biological and biotech industry.

Dr. Gautam Daftary: A qualified medical doctor, Dr. Gautam Daftary is the Managing Director of BSV and spearheads the R&D activities. He also overseas the manufacturing function of the Company. He is also credited with starting the first Indian Clinical Research Company, Siro Clinpharm Private Limited. Dr. Gautam Daftary's knowledge and expertise in the fields of microbiology, oncology, allergies, psychiatrics and infectious diseases has led him to being instrumental in providing the necessary thrust in R&D at BSV.

Mr. Nilesh Ganjwala: Mr.Nilesh Ganjwala is a Chartered Accountant with 18 years of experience in the accounting and financial consulting profession. He has significant experience in corporate taxation, systems audit and financial structuring.

Mr. Shahzaad Dalal: Mr. Shahzaad Dalal is the Executive Vice Chairman of IL&FS Investment Managers Limited. Mr Dalal is a Management Graduate with over 20 years experience. Prior to assuming this responsibility Mr Dalal was the CEO of the Asset Management Strategic Business Unit (ASBU) of IL&FS. He is also on the Board of various IL&FS group companies such as ORIX Auto Finance India Ltd., Noida Toll Bridge Company Ltd.,etc. Mr Dalal was earlier responsible for the overall planning and raising of resources for IL&FS and project finance for IL&FS sponsored infrastructure projects. Prior to joining IL&FS, Mr Dalal was responsible for structured leasing and hire purchase products, marketing and credit evaluation with Industrial Credit and Investment Corporation of India Limited (ICICI).

Dr. Dilip Mehta: Dr. Dilip Mehta is well known in the pharmaceutical research sector globally. He has worked with the several global pharmaceutical companies including Bristol Laboratories (Clinical Laboratories), Hoechst AG and its subsidiaries (Group Director, US Clinical Research), Pfizer Inc. (Sr. Vice President, US Clinical Research), and Quintiles Spectral (India) Limited (Chairman).

Dr. Dilip Mehta has had more than fifty scientific publications relating to methodology of clinical research, pre-clinical work, clinical studies with cardio-vascular drugs etc, in medical journals in the India and the US. He is a consultant with various international committees such as Psychopharmacology Advisory Committee, FDA, 2002, Scientific Board of Cambridge Pharmaceuticals, Inc., Verona New Jersey, Scientific Board of Myomatrix Molecular Technologies LLC, Rensselaer, New York, Supergen Inc. Dublin, California, Scientific Board of Advisor and DataEdge Inc. Philadelphia, Scientific Board of Advisor.

Mr. Prakash Shah: Mr. Prakash Shah is a senior partner in DSK Legal and heads the Direct and Indirect Taxation, Litigation and arbitration practices. A qualified solicitor, Mr. Shah has specialized in advising on complex issues in the fields of Direct and Indirect Taxation, Intellectual Property and General Commercial Litigation. He has provided strategic legal advice and represented several large business houses and multinational companies before a wide variety of fora in diverse legal matters. Mr. Prakash Shah is an Advocate in the High Court of Bombay, a Solicitor in the Supreme Court of India and a Solicitor in the Supreme Court of England and Wales.